These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26922920)

  • 1. The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?
    De Ruysscher D; Vansteenkiste J; Belderbos J; Decaluwé H; Dingemans AM
    J Thorac Oncol; 2016 Mar; 11(3):284-6. PubMed ID: 26922920
    [No Abstract]   [Full Text] [Related]  

  • 2. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current state of the art in treating stage IIIA (N2) lung cancer.
    Martini N
    Ann Oncol; 1998 Mar; 9(3):243-5. PubMed ID: 9602255
    [No Abstract]   [Full Text] [Related]  

  • 6. Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy.
    Thomas PA
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):431-2. PubMed ID: 19524447
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a standard treatment for locally advanced non-small cell lung cancer?
    Buccheri G
    Chest; 1996 Apr; 109(4):864-6. PubMed ID: 8635360
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of stage IIIA non-small cell lung cancer.
    Robinson LA; Wagner H; Ruckdeschel JC;
    Chest; 2003 Jan; 123(1 Suppl):202S-220S. PubMed ID: 12527580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L; Robinson LA; Wagner H
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized or personalized treatment for stage IIIA-N2 non-small-cell lung cancer?
    Vansteenkiste J; Van Damme V; Dooms C
    Expert Opin Pharmacother; 2010 Jul; 11(10):1605-9. PubMed ID: 20497093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer.
    Bograd AJ; Vallières E
    Semin Respir Crit Care Med; 2020 Jun; 41(3):346-353. PubMed ID: 32450588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management algorithms for stage IIIA non-small cell lung cancer with N2 node involvement.
    Detterbeck F; Sukumar MS
    Thorac Surg Clin; 2008 Nov; 18(4):437-41, vii. PubMed ID: 19086612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research.
    Strauss GM; Langer MP; Elias AD; Skarin AT; Sugarbaker DJ
    J Clin Oncol; 1992 May; 10(5):829-38. PubMed ID: 1314892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer.
    Van Schil PE; Yogeswaran K; Hendriks JM; Lauwers P; Faivre-Finn C
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):555-561. PubMed ID: 28403675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma].
    Manegold C; Schirren J; Schneider P; Drings P; Vogt-Moykopf I; Schraube P; Wannenmacher M
    Pneumologie; 1996 Oct; 50(10):735-41. PubMed ID: 9019754
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.